BetweenDevelopment and Commercialization Agreement • October 2nd, 2003 • Aderis Pharmaceuticals Inc • Pharmaceutical preparations • New York
QLT INC. AND XENOVA LIMITEDDevelopment and Commercialization Agreement • March 28th, 2003 • QLT Inc/Bc • Pharmaceutical preparations • England
Exhibit 10.31 THIRD AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • November 14th, 2002 • Durect Corp • Pharmaceutical preparations • California
EXHIBIT 10.75 DEVELOPMENT AND COMMERCIALIZATION AGREEMENT This Development and Commercialization Agreement ("AGREEMENT") is entered into with effect from the 13th day of August, 2001 (the "EFFECTIVE DATE") between QLT Inc. ("QLT"), a company...Development and Commercialization Agreement • November 13th, 2002 • QLT Inc/Bc • Pharmaceutical preparations • England
BetweenDevelopment and Commercialization Agreement • April 25th, 2002 • Aderis Pharmaceuticals Inc • Pharmaceutical preparations • New York
CONFIDENTIAL DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN THIRD WAVE TECHNOLOGIES, INC.Development and Commercialization Agreement • April 1st, 2002 • Aclara Biosciences Inc • Measuring & controlling devices, nec • California
BetweenDevelopment and Commercialization Agreement • January 11th, 2002 • Aderis Pharmaceuticals Inc • New York
EXHIBIT 10.6 SECOND AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • September 1st, 2000 • Durect Corp • Pharmaceutical preparations • California
CONFIDENTIAL EXHIBIT 10.6 SECOND AMENDED AND RESTATED DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • April 20th, 2000 • Durect Corp • California
WITNESSETH:Development and Commercialization Agreement • April 9th, 1999 • Spectrx Inc • Electromedical & electrotherapeutic apparatus • Georgia
1 EXHIBIT 10.24 DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • November 20th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.6 DEVELOPMENT AND COMMERCIALIZATION AGREEMENT THIS DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (together with the attached Schedules, the "Agreement") is made as of this 25th day of September, 1997 (the "Effective Date") by and between...Development and Commercialization Agreement • November 5th, 1997 • Genzyme Transgenics Corp • Biological products, (no disgnostic substances)
1 EXHIBIT 10.24 DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • March 31st, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York